Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Locatelli

Showing results (321-330 of 377) with videos related to

Pageof 38
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 10, 2014
What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study resultsFrancesco Locatelli, Piergiorgio Messa, Antonio Bellasi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2011
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysisSimon D Roger, Francesco Locatelli, Rainer P Woitas, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J L Heerspink, Tom Greene, Hocine Tighiouart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Blood Purification|March 2, 2017
Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter StudyFrancesco Locatelli, Simeone Andrulli, Sara Maria Viganò, et al.
BMC Nephrology|February 26, 2021
The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trialsRobin W M Vernooij, Way Law, Sanne A E Peters, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Nefrologia|May 20, 2018
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patientsJuan J Carrero, Ivan Cabezas-Rodríguez, Abdul R Qureshi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trialsC Marijn Hazelbag, Sanne A E Peters, Peter J Blankestijn, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS studyJosé Luis Fernández-Martín, Pablo Martínez-Camblor, María Paula Dionisi, et al.
Pageof 38

Showing results (321-330 of 377) with videos related to

Sort By:
Pageof 38
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|January 10, 2014
What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study resultsFrancesco Locatelli, Piergiorgio Messa, Antonio Bellasi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 21, 2011
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysisSimon D Roger, Francesco Locatelli, Rainer P Woitas, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J L Heerspink, Tom Greene, Hocine Tighiouart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Blood Purification|March 2, 2017
Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter StudyFrancesco Locatelli, Simeone Andrulli, Sara Maria Viganò, et al.
BMC Nephrology|February 26, 2021
The probability of receiving a kidney transplantation in end-stage kidney disease patients who are treated with haemodiafiltration or haemodialysis: a pooled individual participant data from four randomised controlled trialsRobin W M Vernooij, Way Law, Sanne A E Peters, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Nefrologia|May 20, 2018
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patientsJuan J Carrero, Ivan Cabezas-Rodríguez, Abdul R Qureshi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trialsC Marijn Hazelbag, Sanne A E Peters, Peter J Blankestijn, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS studyJosé Luis Fernández-Martín, Pablo Martínez-Camblor, María Paula Dionisi, et al.
Pageof 38